BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27648372)

  • 1. PET imaging reveals sex differences in kappa opioid receptor availability in humans, in vivo.
    Vijay A; Wang S; Worhunsky P; Zheng MQ; Nabulsi N; Ropchan J; Krishnan-Sarin S; Huang Y; Morris ED
    Am J Nucl Med Mol Imaging; 2016; 6(4):205-14. PubMed ID: 27648372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age.
    Vijay A; Cavallo D; Goldberg A; de Laat B; Nabulsi N; Huang Y; Krishnan-Sarin S; Morris ED
    Neuropsychopharmacology; 2018 Dec; 43(13):2539-2547. PubMed ID: 30188515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey.
    Kim SJ; Zheng MQ; Nabulsi N; Labaree D; Ropchan J; Najafzadeh S; Carson RE; Huang Y; Morris ED
    J Nucl Med; 2013 Sep; 54(9):1668-74. PubMed ID: 23918735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
    Simonin F; Slowe S; Becker JA; Matthes HW; Filliol D; Chluba J; Kitchen I; Kieffer BL
    Eur J Pharmacol; 2001 Mar; 414(2-3):189-95. PubMed ID: 11239918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones.
    Martin M; Matifas A; Maldonado R; Kieffer BL
    Eur J Neurosci; 2003 Feb; 17(4):701-8. PubMed ID: 12603260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel
    Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
    J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation.
    Ji RR; Zhang Q; Law PY; Low HH; Elde R; Hökfelt T
    J Neurosci; 1995 Dec; 15(12):8156-66. PubMed ID: 8613750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.
    Naganawa M; Zheng MQ; Henry S; Nabulsi N; Lin SF; Ropchan J; Labaree D; Najafzadeh S; Kapinos M; Tauscher J; Neumeister A; Carson RE; Huang Y
    J Nucl Med; 2015 Feb; 56(2):243-8. PubMed ID: 25593119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.
    Chartoff EH; Mavrikaki M
    Front Neurosci; 2015; 9():466. PubMed ID: 26733781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
    Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
    Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
    J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid Receptors Gene Polymorphism and Heroin Dependence in Iran.
    Soleimani Asl S; Roointan A; Bergen H; Amiri S; Mardani P; Ashtari N; Shabani R; Mehdizadeh M
    Basic Clin Neurosci; 2018; 9(2):101-106. PubMed ID: 29967669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
    Harland AA; Yeomans L; Griggs NW; Anand JP; Pogozheva ID; Jutkiewicz EM; Traynor JR; Mosberg HI
    J Med Chem; 2015 Nov; 58(22):8952-69. PubMed ID: 26524472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging of kappa opioid receptors and receptor expression quantified in neuron-derived extracellular vesicles in socially housed female and male cynomolgus macaques.
    Johnson BN; Kumar A; Su Y; Singh S; Sai KKS; Nader SH; Li S; Reboussin BA; Huang Y; Deep G; Nader MA
    Neuropsychopharmacology; 2023 Jan; 48(2):410-417. PubMed ID: 36100655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans.
    Naganawa M; Zheng MQ; Nabulsi N; Tomasi G; Henry S; Lin SF; Ropchan J; Labaree D; Tauscher J; Neumeister A; Carson RE; Huang Y
    J Cereb Blood Flow Metab; 2014 Nov; 34(11):1818-25. PubMed ID: 25182664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen facilitates and the kappa and mu opioid receptors mediate antinociception produced by intrathecal (-)-pentazocine in female rats.
    Robinson DL; Nag S; Mokha SS
    Behav Brain Res; 2016 Oct; 312():163-8. PubMed ID: 27312267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors.
    Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A
    J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the development of more effective and safer analgesics for pain management.
    Turnaturi R; Chiechio S; Salerno L; Rescifina A; Pittalà V; Cantarella G; Tomarchio E; Parenti C; Pasquinucci L
    Eur J Med Chem; 2019 Dec; 183():111701. PubMed ID: 31550662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S; Aldrich JV; Walker BM
    Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.